Observation of Treatment Patterns With Lucentis® (Ranibizumab) in Real-life Conditions in All Approved Indications
Latest Information Update: 20 Apr 2021
At a glance
- Drugs Ranibizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 20 Apr 2021 New trial record